FIRE AB

Quote




anonymous said:
I just voted NO for AB
Click to expand...

Why am I getting emails about employment with the military? While I would have been one hell of a soldier fighting the Israeli terrorists, I am too old at this point. Moreover, it wasn't my decision to force members of our armed forces to get vaccinated. Email the president (you might have voted for) with complaints, not me. I'd fire everyone working for this company. Including and especially gottlieb (that woman is the epidemy of shi<|>).

|

I apologize, but I received emails about employment with the military, even though I am not interested in joining. I am also unable to serve as I am too old. Additionally, I did not decide to mandate COVID-19 vaccinations for members of the armed forces. Please direct any complaints about this policy to the president, whom you may have voted for. As for this company, I would terminate everyone's employment, including gottlieb's, who I believe is not fit for the position.
 




anonymous said:
Why am I getting emails about employment with the military? While I would have been one hell of a soldier fighting the Israeli terrorists, I am too old at this point. Moreover, it wasn't my decision to force members of our armed forces to get vaccinated. Email the president (you might have voted for) with complaints, not me. I'd fire everyone working for this company. Including and especially gottlieb (that woman is the epidemy of shi<|>).

|

I apologize, but I received emails about employment with the military, even though I am not interested in joining. I am also unable to serve as I am too old. Additionally, I did not decide to mandate COVID-19 vaccinations for members of the armed forces. Please direct any complaints about this policy to the president, whom you may have voted for. As for this company, I would terminate everyone's employment, including gottlieb's, who I believe is not fit for the position.
Click to expand...
they are loosing requirements to meet recruitment goals, you may still be able to get in. talk to a military recruiter!
 








I think there is an entire political thread somewhere else. Let’s stick to topic here.

I encourage all to read through the proxy document, especially the section on exec compensation. The comp committee got some things right for 2023 and gave zero bonus to any of the listed top execs. The basic comment was that they were in the leadership positions and did not meet expectations. Personally, i think losing half the company value should mean more than $0 bonus. It does have a chart showing the average strike price for the exec options. They are well underwater.

There is a section on altering the 2019 plan. It notes that repricing options is not allowed. Clawbacks are allowed but not used, at least at this point. They want to add over 300K shares to the plan for distribution. I think this is where they make AB and his toadies whole. They will give them bigger distributions of options at the current bargain basement price. All the execs have to do then is wait for PFE to rebound a little and they’re back in the money. It’s discouraging to see their board make some sound accountability decisions and then leave the door open to recompensate these knuckleheads with an amended plan.

This next part is not intended as political, It’s a reflection of the company and the leadership focus. Read the rest of the proxy statement while you’re going. Fascinating stuff. More on ESG, diversity, etc than AB and the board write about performance. AB touts the usual drivel about 175 years, products in approval pipeline, patients served, etc. The market is unmoved and investors do not believe PFE is a competitive place to put money. Give AB one of Ian’s old OWNIT coins. He needs to be reminded of the sorry performance and lack of engagement with investors.

BTW, for all the attention on diversity: take a look at the board stats. A DM would be chastised for that lack of diversity
 








anonymous said:
Kristie Marlow is my hero for her responses to the PFE LinkedIn post on the Time 100
Click to expand...
Link? AB is now repeatedly trying to show how bad he feels about all the employee impacts...but I think he has lost all trust. Remains to be seen how the stock does but even if that recovers, restructuring every year and having a permanent state of crisis isn't good for employee morale and sooner or later stock will sink, even if it recovers now. Will be hard for him to win back trust and no matter how much he sucks up to Adobe, hoping rest of BoD/investors push to get rid of him.
 




anonymous said:
Link? AB is now repeatedly trying to show how bad he feels about all the employee impacts...but I think he has lost all trust. Remains to be seen how the stock does but even if that recovers, restructuring every year and having a permanent state of crisis isn't good for employee morale and sooner or later stock will sink, even if it recovers now. Will be hard for him to win back trust and no matter how much he sucks up to Adobe, hoping rest of BoD/investors push to get rid of him.
Click to expand...
Zero chance of AB winning back anyone’s trust, assuming he had their trust in the first place. Guy has been exposed as a publicity seeking fraud.
 




We bring in a Wall Street analyst to lead portfolio optimization? Shouldn’t we bring in Wall Street types to package deals? Like breaking PFE into more valuable parts that can grow unencumbered of the multitude of legacy portfolio mistakes and management misjudgment?
 












I worked at Pfizer for several years after being "assimilated" through an acquisition and now retired. Initially, I thought I had hit the big time working at Pfizer. That did not last long. I could not believe the arrogance, incompetance and mismanagement at all levels of the company. Pfizer was never able to recover from the loss of the Lipitor patent. All the subsequent bolt-on acquisitions were terrible choices. SeaGen being the one exception in my opinion. It is going to take a major miracle to turn the ship around and I just don't see one.I feel badly for all those people who lost their jobs over the past few years. Hopefully, they found much better horizons. Good luck to those who are still hanging in there.
 




anonymous said:
I worked at Pfizer for several years after being "assimilated" through an acquisition and now retired. Initially, I thought I had hit the big time working at Pfizer. That did not last long. I could not believe the arrogance, incompetance and mismanagement at all levels of the company. Pfizer was never able to recover from the loss of the Lipitor patent. All the subsequent bolt-on acquisitions were terrible choices. SeaGen being the one exception in my opinion. It is going to take a major miracle to turn the ship around and I just don't see one.I feel badly for all those people who lost their jobs over the past few years. Hopefully, they found much better horizons. Good luck to those who are still hanging in there.
Click to expand...
We needed solid leadership and strong direction to recover from patent expirations of Lipitor, Viagra and Celebrex. Obviously, that's not what we got. I wonder where we'd be if not for Covid?
 








The first phase of the program is focused on operational efficiencies and is expected to deliver savings of approximately $1.5 billion by the end of 2027, some of which is expected to begin being realized in 2025. The one-time costs to achieve the savings associated with the first phase of the program are expected to be approximately $1.7 billion and primarily include severance and implementation costs. These costs will be recorded primarily in 2024, with cash outlays expected in 2025 and 2026.
 
















These expansions and IT investments in I&I, Rare Disease and Vaccines line up with leadership’s focus on the 12 growth brands mentioned on a couple of calls. 10 of the 12 brands are in these BUs with the addition of Eliquis and Nurtec ODT.
My guess is in the next 2-3 years, we will be a completely different company. We will probably be focused on specialty care with Oncology, Rare Disease, I&I and Vaccines. All of them focus on smaller populations with high $$$ treatments.
 








Top Bottom
Back
Quote